COVID-19 Antigen Rapid Test Kit

COVID-19 Ag Rapid Test Kit is a rapid lateral flow for the qualitative detection of specific antigen of

SARS-CoV-2 present in human nasal cavity or saliva.

Features:

COVID-19 Antigen Rapid Test Kit

COVID-19 Ag Rapid Test Kit is a rapid lateral flow for the qualitative detection of specific antigen of

SARS-CoV-2 present in human nasal cavity or saliva.

● Our clinical trials of antigen test kit were conducted in laboratories in Germany, Thailand and Greece.

It is CE2934 certified and Thai FDA certified and is listed in the EU Common List.

● The LOD of our test is TCID50 800/ml. The analytical sensitivity is higher than many peers.

● Clinical Sensitivity: 91%, Clinical Specificity: 100%, Clinical Accuracy: 98.36%

● The swabs are our brand iCleanⓇ. Used by 7 EUA approved antigen test manufacturers.

Specific Applications

• Home Self – testing
  People can collect samples and conduct tests at home by themselves without the need to visit medical institutions. It is convenient and quick, enabling an initial judgment of whether they are infected with the novel coronavirus in a short time. This is especially suitable for those with suspected symptoms who are temporarily unable to seek medical treatment, or for individuals to conduct a preliminary screening of their health status during a high – incidence period of the epidemic.
• Primary Screening in Grassroots Medical Institutions
  In some primary hospitals, clinics, etc., the COVID – 19 Antigen Rapid Detection Kit can be used as a primary screening tool. It helps doctors quickly triage patients. For suspected cases, a preliminary judgment can be made rapidly, determining whether further, more accurate testing methods such as nucleic acid testing are required. This contributes to improving the utilization efficiency of medical resources.
• Large – scale Screening
  When conducting large – scale screening in crowded places such as schools, enterprises, and communities, the antigen rapid detection kit can quickly screen a large number of people. Potential infected individuals can be identified in a short time, facilitating the timely implementation of prevention and control measures to prevent the further spread of the epidemic.
• Testing in Special Places
  At transportation hubs such as airports and railway stations, as well as in special places like nursing homes and prisons, the COVID – 19 Antigen Rapid Detection Kit can be used to test people regularly or irregularly. This helps to detect potential infected individuals in a timely manner, ensuring the health and safety of the people in these places.

Advantages

• Rapid and Convenient
  Results can usually be obtained within 15 – 30 minutes, which is a significant reduction compared to the waiting time for nucleic acid testing. This allows people to quickly understand their infection status and take corresponding measures in a timely manner.
• Simple to Operate
  Generally, it does not require professional personnel to operate. Ordinary people can complete the sampling and testing process by themselves according to the instructions, and it is easy to master.
• High Accessibility
  It does not rely on professional laboratory equipment and technicians like nucleic acid testing. It can be used in various scenarios such as homes and communities, improving the accessibility of testing and enabling more people to be tested in a timely manner.
• Relatively Low Cost
  The cost, from the reagent itself to the testing process, is relatively lower than that of nucleic acid testing. In scenarios such as large – scale screening, it can reduce the testing cost.

Disadvantages

• Relatively Low Accuracy
  Especially in the early stage of infection or when the viral load is low, false – negative results may occur, meaning that the actual infection is present but the test result shows negative, carrying a certain risk of missed detection.
• Possible False – positive Results
  False – positive results may occur due to sample contamination, improper operation, etc. That is, the test result shows positive when the person is actually not infected, and further confirmation by methods such as nucleic acid testing is required.
• High Requirement for Testing Timing
  Generally, the testing effect is better 3 – 7 days after infection. If the testing time is too early or too late, it may affect the accuracy of the test results.
• Inability to Distinguish Viral Load
  It can only determine whether there is an infection, and unlike nucleic acid testing, it cannot judge the level of the viral load through indicators such as the Ct value. This has certain limitations in evaluating the severity of the disease, etc.